{
  "ptid_time": "013_S_2324_2011-06-27",
  "img_path": "/data/qiuhui/data/adni/images/013_S_2324/2011-06-27/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 11,678 mm³, 37.3% below the reference mean. With a Z-score of -1.07 (14.3th percentile), this represents mild atrophy; hippocampal volume measures 7,660 mm³, 1.9% below the reference mean. With a Z-score of -0.26 (39.6th percentile), this represents normal volume ; whole brain volume measures 958,873 mm³, 7.8% below the reference mean. With a Z-score of -0.94 (17.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,695 mm³, 0.0% below the reference mean. With a Z-score of -0.00 (50.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,699 mm³, 1.5% above the reference mean. With a Z-score of 0.13 (55.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,928 mm³, 12.7% below the reference mean. With a Z-score of -1.05 (14.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 56.3 years. Gender is Female. Education: 13 years. Handedness: Right. Race: Unknown. Medical history: Neurologic; Musculoskeletal; Gastrointestinal; Major Surgical Procedures. MMSE: 29.0. MoCA: 21.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.99 SUVR (normal ); Amyloid beta: 832.90 pg/mL (normal ); Total tau: 112.80 pg/mL (moderate reduced); Phosphorylated tau: 9.80 pg/mL (moderate reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain imaging shows mild atrophy in ventricular volume and middle temporal gyrus, but hippocampal, whole brain, entorhinal cortex, and fusiform gyrus volumes are within normal ranges. Cognitive testing reveals a discrepancy between MMSE (normal) and MoCA (mild impairment), while biomarkers (Aβ normal, reduced tau) do not strongly support Alzheimer’s pathology.  \n**Diagnosis:** Mild Cognitive Impairment (MCI)  \n**Confidence:** Medium  \n\n*(Note: The MoCA score suggests cognitive impairment, but the lack of significant atrophy or Alzheimer’s biomarker abnormalities makes dementia less likely. The APOE4 carrier status and tau reductions add complexity, warranting further monitoring.)*",
  "timestamp": "2025-07-25T23:29:04.569362"
}